Article
Ratio of the interferon- <i>γ</i> signature to the immunosuppression signature predicts anti-PD-1 therapy response in melanoma
2020-04-18
Abstract excerpt
Immune checkpoint inhibitor (ICI) treatments produce clinical benefit in many patients. However, better pretreatment predictive biomarkers for ICI are still needed to help match individual patients to the treatment most likely to be of benefit. Existing gene expression profiling (GEP)-based biomarkers for ICI are primarily focused on measuring a T cell-inflamed tumour microenvironment that contributes positively t...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 3944a610-e86a-5048-981f-b577e492d35a
- DOI
- 10.1101/2020.04.18.047852
